Impact Biomedical and Zoar announce SEC declares Form F-4 effective, milestone toward closing business combination

Impact Biomedical Inc. and Zoar Limited announced the SEC declared effective their Form F-4 registration statement, marking a major milestone toward closing their proposed business combination.

Detected & updated continuously · Source: Nebula